Recent Headlines
Within Biotechnology
Introducing an Optimized Process Management Concept from Drug Development to Drug Manufacturability: Advaceutics®
Reducing risk, defining time lines and increasing cost efficiency on a new drug’s way to commercial scale manufacturing. - August 26, 2011 - ProJect Pharmaceutics GmbH
NovaTeinBio Introduces New CD Antigens to Company Catalogue
Cambridge, MA-based biomedical innovator and assay development specialist NovaTeinBio has recently announced that they have introduced a new array of products to their existing catalogue of CD antigens. These new products are designed to help medical researchers to increase their understanding of... - August 25, 2011 - Novatein Biosciences
AnaSpec Offers ClearPoint™ β-Amyloid Custom Peptide Synthesis Service
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents, also provides ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled... - August 24, 2011 - AnaSpec, EGT Group
AnaSpec Offers SensoLyte® 520 TACE Assay Kit
While fluorimetric assay kits for the detection and inhibitor screening of Tumor Necrosis Factor alpha (TNF-α) Converting Enzyme (TACE) currently exist, none of these have been able to take full advantage of the performance provided by long wavelength FRET technologies. AnaSpec’s... - August 24, 2011 - AnaSpec, EGT Group
Bioo Scientific Launches Benzo[a]pyrene ELISA to Rapidly Screen Food for Oil Spill Contaminants
The recently released MaxSignal® Benzo[a]pyrene ELISA Kit offers rapid screening of benzo[a]pyrene, a carcinogenic component of petroleum, in fish, shrimp, meat and water samples. - August 23, 2011 - Bioo Scientific
Colorado BioScience Association Serves as Catalyst in Assembling CEO Rountable Discussion for Senator Michael Bennet and FDA Commissioner Margaret Hamburg
The Colorado BioScience Association (CBSA) brought more than 35 industry CEOs together today to dialogue with Senator Michael Bennet and U.S. FDA Commissioner Margaret Hamburg at the Anschutz Medical Campus in Aurora. At Senator Bennet's request, CBSA designed today's session to share the bioscience industry's specific and unique needs in bringing innovative drugs and devices to market under current, often constraining, market conditions. - August 22, 2011 - Colorado BioScience Association
Solar Photovoltaic Installation Workshop at Stevens on August 25
Stevens Institute of Technology is offering a PV installation workshop on August 25 at the build site for the Empowerhouse Solar Decathlon Competition entry. - August 20, 2011 - Stevens Institute of Technology
Dr. Michael Bruno of Stevens Edits Maritime Security Journal Lauded by DHS
The US Department of Homeland Security praised the May/June 2011 issue of the Marine Technology Society Journal as guest edited by Dr. Bruno from Stevens Institute of Technology. - August 20, 2011 - Stevens Institute of Technology
Novus Releases New Mix-and-Match Pathway Assay Kits
Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a... - August 18, 2011 - Novus Biologicals
MoBiTec GmbH, Germany, is Offering Nuclear Receptor Fusion Proteins That Are of Importance to the Pharmaceutical Industry for FRET Interaction Studies
MoBiTec GmbH, Germany, supplier of research tools, introduces a collection of Nuclear Receptor-Ligand Binding Domain fusion proteins, carrying a GST tag, capable to bind a Europium-anti-GST antibody. With this the influence of fluorophore-labeled peptides on the ligand binding characteristics can be studied. E.g. the addition of a particular peptide might prevent the receptor from binding a ligand, thereby eliminating a response of a cell to a given stimulus. - August 17, 2011 - MoBiTec GmbH
Mouse Monoclonal DUX4 Antibody Announced by Novus Biologicals
DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD... - August 17, 2011 - Novus Biologicals
AnaSpec Highlights Calcein AM with High Purity Grades
AnaSpec is pleased to provide Calcein AM at two purity grades, >90% or >95%, as determined by HPLC. AnaSpec also offers the SensoLyte® Calcein Cell Viability Assay Kit - a rapid and sensitive assay to detect viable cells. This kit provides ample reagents (dye and assay buffer) for 1000... - August 14, 2011 - AnaSpec, EGT Group
AnaSpec Offers Monoclonal Antibody, Anti-5-Methylcytidine
AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - August 14, 2011 - AnaSpec, EGT Group
Professor Attygalle of Stevens Lectures at a Max Planck Institute on Mass Spectrometry
Mass spectrometry expert Dr. Athula Attygalle from Stevens Institute of Technology lectured at a Max Planck Institute in Jena, Germany, earlier this summer. - August 11, 2011 - Stevens Institute of Technology
Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor Conference in Denver
The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - August 10, 2011 - Colorado BioScience Association
FDA Supplier Management Conference Chaired by Cerulean's John Avellanet
Cerulean's John Avellanet will chair a three-day conference of FDA officials and industry veterans discussing key regulatory requirements and industry best practices for managing suppliers and conducting supplier qualification. - August 05, 2011 - Cerulean Associates LLC
SalesForce4Hire® Releases White Paper on a "Shared Risk – Shared Reward" Sales Model
Leading Custom Sales Solutions Company Addresses Advantages of a Strategic Sales Partner Over Traditional Outsourced Sales Organizations - August 05, 2011 - SalesForce4Hire
Mitegen Announces Distribution of AP Innovation's Quick Puck Loader
Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC
Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Flashback Technologies
The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Longmont, CO-based Flashback Technologies, Inc. to receive funding and management assistance. - August 03, 2011 - Colorado Institute for Drug, Device and Diagnostic Development
Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals
Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals
AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody
Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011 - AbboMax, Inc.
BioPharm Systems to Present at the 16th Annual Oracle Health Sciences User Group Meeting
Leading IT consulting company focused on the implementation and hosting of clinical trial software will speak at Oracle's annual event. - August 03, 2011 - BioPharm Systems
Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™
Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals
New Products Now Available Via the NovaTeinBio Website
Boston based biological reagents provider, NovaTeinBio Inc. has recently announced that they have added new products to their varied catalogue. The new products are an addition to the already outstanding array of solutions that the company offers to their clients across the scientific... - July 31, 2011 - Novatein Biosciences
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says
A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Stevens Professor EH Yang Receives DURIP Grant to Support Nanoscale Imaging
Dr. Yang's AFOSR-sponsored DURIP grant allows him to purchase a scanning probe microscope capable of imaging in ambient conditions. - July 29, 2011 - Stevens Institute of Technology
Dr. Chandramouli of Stevens Gives Keynote on Dynamic Spectrum Access at Wireless Security Conference
Dr. R. Chandramouli of Stevens gave the Wireless Summit track keynote lecture, “Dynamic Spectrum Access Wireless Networking," at the NIKSUN World Wide Security & Mobility Conference 2011 (NIKSUN WWSMC) in Princeton, NJ, on July 27. - July 29, 2011 - Stevens Institute of Technology
Colorado Institute for Drug, Device and Diagnostic Development Sets August 5th as Submission Date for New Project Consideration
The Colorado Institute for Drug, Device and Diagnostic Development (CID4) is seeking its fifth project and a review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration. - July 27, 2011 - Colorado Institute for Drug, Device and Diagnostic Development
Exploring Science Through Underwater Robotics
The Center for Innovation in Engineering and Science Education at Stevens is leading a National Science Foundation initiative to improve K-12 STEM skills and education through fun summer camps and educator institutes. - July 27, 2011 - Stevens Institute of Technology
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc
Stevens Students Win 5th in International Autonomous Surface Vehicle Competition
The Stevens team won 5th at the International RoboBoat Competition, held June 9-12 in Virginia Beach. - July 21, 2011 - Stevens Institute of Technology
Valencia Practice Adpots New and Discreet STARR Weight-Loss Treatment
Town Center Surgery’s Dr. Monali Misra praises privacy and comfort of new procedure, no visible scars. - July 21, 2011 - TransEnterix
AnaSpec Releases Anti-LL-37
AnaSpec is pleased to announce the release of a new anti-LL-37. Rabbit Anti-human Cathelicidin LL-37 polyclonal antibody was raised against a synthetic peptide from a sequence found within 134-170 amino acid residues (LL-37) of the LL-37 precursor human cationic antimicrobial protein, hCAP-18... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Expands SensoLyte® MMP Assay Kits Collection
Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Specializes in Custom Peptide Synthesis
Since 1993, AnaSpec has assisted scientists in the design and synthesis of >50,000 peptides. As a result, AnaSpec's combined knowledge and expertise provide premium solutions to its customers. AnaSpec routinely completes difficult peptide synthesis such as synthesis of long peptides... - July 15, 2011 - AnaSpec, EGT Group
NanoSort, Inc. Awarded NIH “Lab to Marketplace” SBIR Grant to Develop Next-Generation Flow Cytometer and Cell Sorter
The National Institutes of Health awarded technology start-up NanoSort, Inc. a 2 year, $698,000 small business innovation research (SBIR) grant. Granted by NIH’s National Center for Research Resources (NCRR), this SBIR will enable NanoSort to advance their development of next-generation... - July 14, 2011 - NanoSort
Stevens Institute of Technology Hosted Biomaterials Research Conference
The Stevens Conference on Bacteria-Material Interactions was a space for discussing future-oriented strategies critical to developing safer, more effective biomaterials that promote healing while minimizing the risk of infection. - July 09, 2011 - Stevens Institute of Technology
2nd International Conference on Tocotrienols and Chronic Diseases at Wynn Resort, Las Vegas, July 2011
Latest research studies, technical application as well as market potential of palm tocotrienol complex will be shared in this conference. - July 08, 2011 - Carotech Inc.
New Virus Modification Approach to Creating Vaccines for Insect-Borne Diseases
A technology breakthrough that could have a major impact in the development of vaccines to preventive insect-borne diseases has been published in the June edition of Virology Journal, - July 07, 2011 - Arbovax Inc
BioPharm Systems to Present the Top 10 Reasons Why Life Sciences Companies Need a Clinical Trial Management System
The free one-hour webinar will discuss the top ten reasons why it makes sense for organizations to invest in a CTMS. - July 07, 2011 - BioPharm Systems
BioPharm Systems to Host Webinar on Flexible Study Design in Oracle Clinical and Remote Data Capture
The free one-hour webinar will examine the new flexible study design features in the latest version of OC/RDC. - July 07, 2011 - BioPharm Systems
BioPharm Systems to Host Webinar on Using Siebel Clinical for Your Specific Job Function
The free one-hour webinar will explore how Oracle's CTMS can be used by the six most common clinical trial management job functions. - July 07, 2011 - BioPharm Systems
Red Cedar Technology Positions Itself for Rapid Growth
Consistent Performance Relative to Aggressive Growth Plan Leads to Promotions - July 02, 2011 - Red Cedar Technology
Dr. Masoud Toloue will Describe Methyl-Seq, PCR-Free and Small RNA-Seq NGS Library Prep Technologies
This week at the European Next Generation Sequencing Congress in Hamburg, Germany, Dr. Masoud Toloue of Bioo Scientific will describe the latest improvements in DNA and RNA library prep technologies for NGS. - June 30, 2011 - Bioo Scientific
Novus Biologicals Announces Opening of Canadian Office
Novus Biologicals, an international supplier of antibodies and antibody-related products to bioscience researchers, is proud to announce the opening of their second international office in Oakville, Ontario, Canada. Novus' other offices include Novus Europe, which services Europe from Cambridge,... - June 30, 2011 - Novus Biologicals
Colorado BioScience Association Showcases Colorado's Bioscience Industry at BIO 2011 Conference in Washington DC, June 27-30
Colorado BioScience Association (CBSA) will head the Colorado Pavilion at the Biotechnology Industry Organization’s (BIO) International Convention in Washington DC, June 27-30. The Colorado Pavilion, located in booth # 2107 of the Exhibit Hall area, includes a number of companies and partners helping to grow the bioscience industry in the state. - June 29, 2011 - Colorado BioScience Association
Mitegen Awarded $250K NIH STTR Phase II Grant
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a phase II STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of improved crystallization plates. - June 27, 2011 - MiTeGen, LLC
Clinical Trials in Russia. Year 2010.
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) and the Ministry of Health and Social Development of the Russian Federation (MoH) approved 492 new clinical trials of all types including local and bioequivalence studies during 2010, demonstrating a 15% decrease from the last year figure. - June 27, 2011 - Synergy Research Group
Industry Professor Elaine Pratt Named Co-op Advisor of the Year at Stevens
Industry Professor Elaine Pratt has been recognized by the Stevens Institute of Technology Office of Cooperative Education as the 2011 Academic Advisor of the Year for her work with Pharmaceutical Manufacturing graduate students. - June 25, 2011 - Stevens Institute of Technology
Stevens Selected to Host 2012 IEEE SAM Workshop
Stevens Institute of Technology has recently been announced as host of the IEEE 2012 Sensor Array and Multichannel Signal Processing Workshop (SAM 2012). The biennial SAM Workshop will be held on Stevens campus in Hoboken, New Jersey on June 17-20, 2012. - June 24, 2011 - Stevens Institute of Technology